These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11230836)

  • 21. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
    Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
    Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
    Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
    Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
    Gadzhiev AN
    Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.
    Oosterga M; Voors AA; Buikema H; Pinto YM; Haber HE; Ebels T; Morshuis WJ; Kingma JH; Crijns HJ; van Gilst WH
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):55-60. PubMed ID: 10755201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for ACE inhibition as an anti-ischaemic therapy.
    Pepine CJ
    Eur Heart J; 1998 Jul; 19 Suppl G():G34-40. PubMed ID: 9717054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 32. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
    Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
    Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
    Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
    Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Holter monitoring to improve the sensitivity of exercise testing in determining the degree of myocardial revascularization after coronary artery bypass grafting for stable angina pectoris.
    Crea F; Kaski JC; Fragasso G; Hackett D; Stanbridge R; Taylor KM; Maseri A
    Am J Cardiol; 1987 Jul; 60(1):40-3. PubMed ID: 3496778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.